Audio pioneer Dolby Laboratories (DLB) has made significant strides recently. The company has partnered with brands such as ...

For the purpose of designing the patient-based model for Dementia with Lewy Bodies (DLB), the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of ...

February 05, 2025, 09:04 am ET, BY Robert S.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Check the time ...

Dolby Laboratories Inc DLB is slated to report first-quarter fiscal 2025 results on Jan. 29. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for ...

Dolby Laboratories (DLB) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from ...

We are neutral on Dolby Labs due to limited upside potential despite revenue growth and strong balance sheet in FQ1 2025. Read an analysis of DLB stock here.

The Lady Lakers hosted the South Prairie-Max Royals at the dock for some region 3 basketball action. The Royals held a 17 ...

Dolby Laboratories (DLB) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago.

About Dementia with Lewy Bodies (DLB) DLB is the third most common degenerative disease of the brain (after Alzheimer’s disease and Parkinson’s disease), with approximately 700,000 individuals ...